The Direct-to-Consumer Genetic Testing Market is set to exceed USD 2.5 billion by 2024; according to a new research report by Global Market Insights. Growing incidences of genetic and rare disorders worldwide coupled with wide applications of direct-to-consumer genetic testing in early detection and prevention of oncology as well as other genetic diseases will drive the Direct-to-Consumer Genetic Testing Market growth in the coming years. Rising awareness among patients pertaining to early disease diagnosis will result in timely treatment and reduced mortality rate. Additionally, technological innovations in direct-to-consumer genetic testing to offer enhanced efficiency, high sensitivity and accuracy will serve to be a significant impact rendering factor. Moreover, increasing adoption of carrier testing at a very early stage of pregnancy will further augment the business growth during forecast period.
Request for a sample of this research report @ www.gminsights.com/request-sample/detail/3033
Increasing demand for service personalization in developed regions such as North America and Europe is the key factor that will drive the direct-to-consumer (DTC) genetic testing industry growth. These tests enable consumers to know their genetic information without involvement of physicians and other healthcare professionals. DTC testing allows consumers to determine genetic predisposition to diabetes, cancer, Alzheimer’s and other genetic diseases in order to enable precautionary preparation for healthcare. This will surge the demand for DTC genetic tests thereby augmenting industry growth over the forecast period. However, the high cost involved in direct-to-consumer genetic testing kits coupled with defects in the DTC genetic tests may hamper the industry growth in the foreseeable future.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Color Genomics
• Family Tree DNA
• Full Genomes, Inc.
• Genesis Healthcare System
• Karmagenes SA
• Living DNA
• Pathway Genomics Corporation
Predictive testing segment held USD 110.8 million revenue in 2017 and will witness robust growth in the coming years. Predictive tests enables identification of genetic mutation before actual manifestation resulting in early disease diagnosis. Diagnosis of chronic disease such as cancer at an early stage can make significant improvements in the lives of cancer patients resulting in reduced morbidity, greater probability of surviving and less expensive treatment. As per the Institute for Health Metrics and Evaluation (IHME), approximately 8.9 million cancer deaths were noted during 2016, wherein more than 5% of all the cancers globally were caused due to inheriting genetic mutation. Growing prevalence of cancer globally will augment the segment growth over the analysis timeframe.
Targeted analysis technology segment accounted for considerable revenue share in 2017 and is projected to show lucrative 17.6% CAGR during the forthcoming years. The segmental growth is attributed to growing advancements in technology for diagnosis of various chronic diseases. Increasing adoption of targeted analysis in genetic testing for cardiomyopathy to assess coding regions of more than 50 genes will further boost the market growth. Hence, availability of such advanced technologies will accelerate the segment growth during the forecast period.
U.S. Direct-to-Consumer Genetic Testing Market accounted for more than 91% revenue share of total North America Market in 2017 and will show robust growth over the analysis period. The growth is attributed to the rising incidences of genetic diseases in the country, high awareness among people regarding genetic testing as well as technological advancements. Moreover, regulatory support for direct to consumer genetic testing coupled with high healthcare spending will boost the business growth over the forecast timeline.
Japan direct-to-consumer genetic testing market held considerable revenue in 2017 and is estimated to grow at 18.2% CAGR by 2024. Increasing government investment in R&D, rapid technological advancements, availability of new tests as well as large patient pool in the country will surge the demand for DTC genetic testing in early disease diagnosis. Furthermore, increasing prevalence of cancer and other genetically inherited diseases coupled with increasing healthcare expenditure will further drive the Japan Direct-to-Consumer Genetic Testing Market.
Make an inquiry for purchasing this report @ www.gminsights.com/inquiry-before-buying/3033
Chapter 1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
126.96.36.199. Paid sources
188.8.131.52. Unpaid sources
Chapter 2. Executive Summary
2.1. Direct-to-consumer (DTC) genetic testing industry 360º synopsis, 2014 – 2024
2.1.1. Business trends
2.1.2. Test type trends
2.1.3. Technology trends
2.1.4. Regional trends
Chapter 3. Direct-to-Consumer (DTC) Genetic Testing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
184.108.40.206. Rising public awareness in North America
220.127.116.11. Increasing income level in emerging economies
18.104.22.168. Growing incidences of genetic disorders globally
22.214.171.124. Increasing demand for service personalization in North America and Europe
3.3.2. Industry pitfalls & challenges
126.96.36.199. High cost of DTC genetic testing
188.8.131.52. Defects in the DTC testing kits
Chapter 4. Direct-to-Consumer (DTC) Genetic Testing Market, By Test Type
4.1. Key segment trends
4.2. Carrier testing
4.2.1. Carrier testing market, by region, 2014-2024 (USD Million)
4.2.2. Carrier testing market, by region, 2014-2024 (000’ Units)
4.3. Predictive testing
4.3.1. Predictive testing market, by region, 2014-2024 (USD Million)
4.3.2. Predictive testing market, by region, 2014-2024 (000’ Units)
4.4. Ancestry & relationship testing
4.4.1. Ancestry & relationship testing market, by region, 2014-2024 (USD Million)
4.4.2. Ancestry & relationship testing market, by region, 2014-2024 (000’ Units)
4.5. Nutrigenomics testing
4.5.1. Nutrigenomics testing market, by region, 2014-2024 (USD Million)
4.5.2. Nutrigenomics testing market, by region, 2014-2024 (000’ Units)
4.6.1. Others market, by region, 2014-2024 (USD Million)
4.6.2. Others market, by region, 2014-2024 (000’ Units)
Browse Full Report Details @ www.gminsights.com/industry-analysis/direct-to-consumer-d…
TABLE 1. Direct-to-Consumer genetic testing industry 360° synopsis, 2014 – 2024
TABLE 2. Global direct-to-consumer genetic testing market, 2014 – 2024 (USD Million)
TABLE 3. Global direct-to-consumer genetic testing market, 2014 – 2024 (000’ Units)
TABLE 4. Global direct-to-consumer genetic testing market, by test type, 2014 – 2024 (USD Million)
TABLE 5. Global direct-to-consumer genetic testing market, by test type, 2014 – 2024 (000’ Units)
TABLE 6. Global direct-to-consumer genetic testing market, by technology, 2014 – 2024 (USD Million)
TABLE 7. Global direct-to-consumer genetic testing market, by region, 2014 – 2024 (USD Million)
TABLE 8. Global direct-to-consumer genetic testing market, by region, 2014 – 2024 (000’ Units)
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Toll Free: 1-888-689-0688
This release was published on openPR.